Clinical Focus: Gastrointestinal and thoracic surgical oncology requires rigorous adherence to anatomical planes, radical lymphadenectomy, and precise digestive reconstruction. Dr. Malyadri Paladugu provides specialized surgical leadership for stomach (gastric), colon, rectal, and esophageal/lung malignancies using advanced laparoscopic, robotic, and open approaches.

Gastrointestinal & Thoracic Cancers Managed

Stomach / Gastric Cancer: Laparoscopic & Open Radical Subtotal and Total Gastrectomy with D2 Lymph Node Dissection and Roux-en-Y reconstruction.
Colorectal Cancer (Colon & Rectum): Laparoscopic & Robotic Right/Left Hemicolectomy, Sigmoidectomy, and Total Mesorectal Excision (TME) for Rectal Cancer with sphincter preservation.
Gastrointestinal Stromal Tumors (GIST): Laparoscopic wedge resection of stomach and small intestine tumors.
Esophageal Malignancies: Transthoracic (Ivor Lewis) and Thoracolaparoscopic Esophagectomy with gastric conduit pull-up.
Thoracic Oncology (Lung & Mediastinum): VATS / Open Lobectomy and mediastinal lymph node clearance for Non-Small Cell Lung Cancer (NSCLC) and thymomas.
Retroperitoneal Sarcomas & GI Malignancies: Multi-visceral en-bloc resections with clear margin control.

Diagnostic Staging & Multimodal Assessment

Endoscopy & Colonoscopy

High-definition upper GI endoscopy and full colonoscopy with tissue biopsies and lesion tattooing.

Contrast CT & PET-CT

Triphasic CECT Abdomen & Pelvis with high-resolution pelvic MRI for rectal cancer circumferential margin (CRM) mapping.

Nutritional Optimization

Pre-operative nutritional assessment, serum albumin optimization, and immunonutrition counseling.

Surgical Excellence & Sphincter Preservation

D2 Lymphadenectomy: Removing all designated second-tier perigastric lymph nodes to maximize long-term disease-free survival in stomach cancer.
Total Mesorectal Excision (TME): Meticulous dissection along the holy plane of the mesorectum to minimize local recurrence rates in rectal cancer.
Sphincter-Saving Ultra-Low Anterior Resection (Intersphincteric Resection): Preserving natural bowel continuity and avoiding permanent colostomies wherever oncologically safe.
Enhanced Recovery (ERAS): Early feeding, minimal drain usage, and non-opioid multimodal analgesia for quick digestive recovery.

Why Choose Karthikeya Speciality Clinics

Surgical Oncology Specialization: Dr. Malyadri Paladugu has extensive expertise in radical D2 gastrectomies and robotic rectal surgery.
Sphincter Preservation Focus: Dedicated efforts to preserve natural bowel continuity and avoid permanent stomas whenever feasible.
Tertiary Hospital Infrastructure: Performing complex GI surgical oncology at Yashoda Hospital Hitech City with modern stapling devices and ICU support.
Multidisciplinary GI Tumor Board: Coordinated care with medical and radiation oncologists for optimal combined-modality treatment.

Frequently Asked Questions

In the majority of rectal cancer cases today, advanced robotic and laparoscopic Total Mesorectal Excision (TME) allows preservation of the anal sphincter, avoiding a permanent stoma. A temporary protective stoma is sometimes placed for 6 to 8 weeks to allow the new internal bowel join to heal safely.

D2 lymphadenectomy is the standard-of-care surgical removal of all lymph node stations surrounding the major arteries of the stomach (celiac axis, hepatic, splenic, and left gastric arteries). It significantly reduces the risk of cancer recurrence.

Persistent change in bowel habits (diarrhea or constipation lasting several weeks), unexplained rectal bleeding, blood mixed in stool, abdominal discomfort, unexplained anemia, or significant weight loss should be evaluated by colonoscopy.

← Back to General Surgery & Surgical Oncology Book Consultation →

Thoracic, Stomach & Colorectal Cancer Surgeries